Express News | Ovid Therapeutics Inc - Receives Nasdaq Notice for Minimum Bid Price Non-Compliance

ReutersFeb 13 17:16 ET

Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

GlobeNewswireFeb 5 08:00 ET

Oppenheimer Upgrades Ovid Therapeutics(OVID.US) to Buy Rating, Announces Target Price $4

Moomoo NewsJan 30 01:32 ET · Ratings

Oppenheimer Upgrades Ovid Therapeutics to Outperform From Perform, $4 Price Target

MT NewswiresJan 29 10:28 ET · Ratings

Ovid Therapeutics Insider Ups Holding During Year

Yahoo FinanceJan 23 06:18 ET

Ovid Therapeutics' OV329: Promising Safety and Efficacy Lead to Buy Rating

TipRanksDec 10, 2024 07:05 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM) and Ovid Therapeutics (OVID)

TipRanksDec 9, 2024 08:20 ET · Ratings

H.C. Wainwright Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsDec 5, 2024 11:35 ET · Ratings

Ovid Therapeutics Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

Dow JonesDec 4, 2024 06:59 ET · Ratings

Wedbush Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsNov 14, 2024 09:33 ET · Ratings

TD Cowen Maintains Ovid Therapeutics(OVID.US) With Buy Rating

Moomoo NewsNov 13, 2024 23:32 ET · Ratings

Ovid Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 12, 2024 09:41 ET · Announcements

Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results

SECNov 12, 2024 09:40 ET

Ovid Therapeutics Reports Q3 EPS (20c), Consensus (20c)

TipRanksNov 12, 2024 08:11 ET

Earnings Flash (OVID) OVID THERAPEUTICS Reports Q3 Revenue $173,000

MT NewswiresNov 12, 2024 08:05 ET

Express News | Ovid Therapeutics Q3 Operating Expenses USD 13.399 Million

ReutersNov 12, 2024 08:00 ET

Express News | Ovid Therapeutics Q3 Net Income USD -14.006 Million

ReutersNov 12, 2024 08:00 ET

Press Release: Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results

Dow JonesNov 12, 2024 08:00 ET

Ovid Therapeutics to Host Investor Event

GlobeNewswireOct 31, 2024 08:00 ET

12 Health Care Stocks Moving In Wednesday's After-Market Session

BenzingaOct 16, 2024 16:31 ET